Order Article Reprints

Széles Á, Kovács PT, Csizmarik A, Váradi M, Riesz P, Fazekas T, Váncsa S, Hegyi P, Oláh C, Tschirdewahn S, et al. High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma. Biomedicines. 2022; 10(10):2560. https://doi.org/10.3390/biomedicines10102560

Széles, Ádám, Petra Terézia Kovács, Anita Csizmarik, Melinda Váradi, Péter Riesz, Tamás Fazekas, Szilárd Váncsa, Péter Hegyi, Csilla Oláh, Stephan Tschirdewahn, and et al. 2022. "High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma" Biomedicines 10, no. 10: 2560. https://doi.org/10.3390/biomedicines10102560

Széles, Á., Kovács, P. T., Csizmarik, A., Váradi, M., Riesz, P., Fazekas, T., Váncsa, S., Hegyi, P., Oláh, C., Tschirdewahn, S., Darr, C., Krafft, U., Grünwald, V., Hadaschik, B., Horváth, O., Nyirády, P., & Szarvas, T. (2022). High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma. Biomedicines, 10(10), 2560. https://doi.org/10.3390/biomedicines10102560